ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 234 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,591,000 | -42.2% | 89,888 | -36.2% | 0.00% | -50.0% |
| Q3 2016 | $4,483,000 | +9.4% | 140,925 | +11.6% | 0.00% | 0.0% |
| Q2 2016 | $4,097,000 | +73.6% | 126,227 | +49.6% | 0.00% | +100.0% |
| Q1 2016 | $2,360,000 | +10.1% | 84,381 | +40.3% | 0.00% | 0.0% |
| Q4 2015 | $2,144,000 | +16.5% | 60,144 | +8.0% | 0.00% | 0.0% |
| Q3 2015 | $1,841,000 | -4.9% | 55,676 | +20.5% | 0.00% | 0.0% |
| Q2 2015 | $1,936,000 | +42.4% | 46,215 | +10.8% | 0.00% | 0.0% |
| Q1 2015 | $1,360,000 | +42.4% | 41,715 | +38.7% | 0.00% | 0.0% |
| Q4 2014 | $955,000 | +55.3% | 30,085 | +21.3% | 0.00% | – |
| Q3 2014 | $615,000 | +8.1% | 24,804 | -1.4% | 0.00% | – |
| Q2 2014 | $569,000 | -46.2% | 25,164 | -42.2% | 0.00% | -100.0% |
| Q1 2014 | $1,058,000 | +92.4% | 43,505 | +97.5% | 0.00% | – |
| Q4 2013 | $550,000 | -92.6% | 22,033 | -91.9% | 0.00% | -100.0% |
| Q3 2013 | $7,457,000 | -27.4% | 271,461 | -52.0% | 0.01% | -37.5% |
| Q2 2013 | $10,268,000 | – | 565,761 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |